Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
Want to see APLS full AI Analyst Report?
APLS Analyst Ratings
Hold
2 Buy
13 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
APLS Stock 12 Month Forecast
Average Price Target
$40.00
▼(-2.20% Downside)
| Highest Price Target$41.00 | Average Price Target$40.00 | Lowest Price Target$28.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
$41.03→$41
Hold
0.24%
Upside
Reiterated
05/11/26
RBC Capital
$41
Hold
0.24%
Upside
Reiterated
05/08/26
Roth MKM
$31→$41
Hold
0.24%
Upside
Downgraded
04/02/26
J.P. Morgan
$37→$41
Hold
0.24%
Upside
Downgraded
04/01/26
H.C. Wainwright
$48→$41
Hold
0.24%
Upside
Downgraded
04/01/26
Stifel Nicolaus
$48→$41
Hold
0.24%
Upside
Downgraded
04/01/26
Raymond James
$45→$41
Hold
0.24%
Upside
Downgraded
04/01/26
Barclays
$24→$41
Hold
0.24%
Upside
Assigned
04/01/26
Robert W. Baird
$41
Hold
0.24%
Upside
Downgraded
04/01/26
Needham
―
Hold
―
Downgraded
03/31/26
Jefferies
$41
Hold
0.24%
Upside
Downgraded
03/31/26
Citi
$44→$41
Hold
0.24%
Upside
Downgraded
03/31/26
Morgan Stanley
$25→$41
Hold
0.24%
Upside
Assigned
03/31/26
TD Cowen
$45→$40
Buy
-2.20%
Downside
Reiterated
02/24/26
Bank of America Securities
$28
Buy
-31.54%
Downside
Reiterated
02/24/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
$41.03→$41
Hold
0.24%
Upside
Reiterated
05/11/26
RBC Capital
$41
Hold
0.24%
Upside
Reiterated
05/08/26
Roth MKM
$31→$41
Hold
0.24%
Upside
Downgraded
04/02/26
J.P. Morgan
$37→$41
Hold
0.24%
Upside
Downgraded
04/01/26
H.C. Wainwright
$48→$41
Hold
0.24%
Upside
Downgraded
04/01/26
Stifel Nicolaus
$48→$41
Hold
0.24%
Upside
Downgraded
04/01/26
Raymond James
$45→$41
Hold
0.24%
Upside
Downgraded
04/01/26
Barclays
$24→$41
Hold
0.24%
Upside
Assigned
04/01/26
Robert W. Baird
$41
Hold
0.24%
Upside
Downgraded
04/01/26
Needham
―
Hold
―
Downgraded
03/31/26
Jefferies
$41
Hold
0.24%
Upside
Downgraded
03/31/26
Citi
$44→$41
Hold
0.24%
Upside
Downgraded
03/31/26
Morgan Stanley
$25→$41
Hold
0.24%
Upside
Assigned
03/31/26
TD Cowen
$45→$40
Buy
-2.20%
Downside
Reiterated
02/24/26
Bank of America Securities
$28
Buy
-31.54%
Downside
Reiterated
02/24/26
Best Analysts Covering Apellis Pharmaceuticals
3 Months
Success Rate
15/28 ratings generated profit
Average Return
+4.67%
Copying Phil Nadeau's trades and holding each position for 3 Months would result in 53.57% of your transactions generating a profit, with an average return of +4.67% per trade.
1 Year
Success Rate
11/28 ratings generated profit
Average Return
+4.31%
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 39.29% of your transactions generating a profit, with an average return of +4.31% per trade.
2 Years
Success Rate
18/28 ratings generated profit
Average Return
+20.18%
Copying Phil Nadeau's trades and holding each position for 2 Years would result in 64.29% of your transactions generating a profit, with an average return of +20.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
APLS Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
10
11
12
7
3
Buy
11
13
12
4
1
Hold
11
16
23
27
26
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
40
47
38
30
Each month's total comprises the sum of three months' worth of ratings.
APLS Financial Forecast
APLS Stock Forecast FAQ
What is APLS’s average 12-month price target, according to analysts?
Based on analyst ratings, Apellis Pharmaceuticals Inc’s 12-month average price target is 40.00.
What is APLS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for APLS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APLS a Buy, Sell or Hold?
Apellis Pharmaceuticals Inc has a consensus rating of Hold which is based on 2 buy ratings, 13 hold ratings and 0 sell ratings.
What is Apellis Pharmaceuticals Inc’s price target?
The average price target for Apellis Pharmaceuticals Inc is 40.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $41.00 ,the lowest forecast is $28.00. The average price target represents -2.20% Decrease from the current price of $40.9.
The highest analyst price target is $41.00 ,the lowest forecast is $28.00. The average price target represents -2.20% Decrease from the current price of $40.9.
What do analysts say about Apellis Pharmaceuticals Inc?
Apellis Pharmaceuticals Inc’s analyst rating consensus is a Hold. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of APLS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.